|
|
||||||||
Clinical Chemistry, Vol 39, 196-201, Copyright © 1993 by American Association for Clinical Chemistry
E Lopez, C Chypre, B Alpha and G Mathis
CIS Bio International, Laboratoire des Produits pour l'Analyse Medicale, Bagnols sur Ceze, France.
We report a method for the nonradioactive detection of specific amplified target DNA, based on a new long-lived fluorescent label, europium(III) trisbipyridine cryptate [TBP-(Eu3+)]. After a polymerase chain reaction with a set of nested primers, microtiter affinity- collected hybrids were recognized by a TBP(Eu3+)-labeled antibody. The particular structure of the label containing the energy transfer units (bipyridine moieties) enables direct fluorescence measurement on the solid phase. Moreover, its stability and long lifetime contribute to the enhancement of the signal-to-noise ratio. The usefulness of this new label is illustrated by the detection of human papillomavirus type 16 DNA in clinical smears.
The following articles in journals at HighWire Press have cited this article:
![]() |
E. Lopez-Crapez, H. Bazin, E. Andre, J. Noletti, J. Grenier, and G. Mathis A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer Nucleic Acids Res., July 15, 2001; 29(14): e70 - e70. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |